We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Adenylate Kinase Activity Controls Cystic Fibrosis Channel Protein

By Biotechdaily staff writers
Posted on 12 Feb 2004
A recent study suggests that the mechanism by which the cystic fibrosis transmembrane conductance regulator protein (CFTR) opens ion channels in lung cells is that of an adenylate kinase enzyme and not that of an ATPase as had been previously believed.

Adenylate kinase catalyzes the phosphorylation of adenosine 5'-phosphate (AMP) to adenosine 5'-disphosphate (ADP) in the presence of ATP or inorganic triphosphate in a reaction that neither requires nor releases energy. More...
This type of reaction better fits the evidence indicating that while ATP is required for CFTR channel formation, energy such as that provided by ATPase breakdown of ATP is not required for ions to flow through the channel.

Investigators at the University of Iowa (Iowa City, USA) revealed in the December 26, 2003, issue of Cell that at physiologic nucleotide concentrations, adenylate kinase activity, rather than ATPase activity, may control gating (the process by which ion channels open and close their pores) and therefore involve little energy consumption.
CFTR is a member of the ABC transporter family, the largest group of proteins that move molecules across membranes. "ABC transporter proteins contain a very conserved ‘engine' that controls transport,” explained Dr. Chrisoph Randak, a postdoctoral investigator at the University of Iowa. "Our study indicates that at least in CFTR that ‘engine' can be run either by an ATPase, which uses energy, or an adenylate kinase, which is energy-neutral.”




Related Links:
University of Iowa

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.